Market Closed -
Other stock markets
|
After market 21:00:02 | |||
1.32 EUR | -2.22% | 1.41 | +6.82% |
Sales 2024 * | 39.35M 36.2M 3.08B | Sales 2025 * | 58.17M 53.51M 4.55B | Capitalization | 79.1M 72.77M 6.18B |
---|---|---|---|---|---|
Net income 2024 * | -119M -109M -9.3B | Net income 2025 * | -78M -71.75M -6.1B | EV / Sales 2024 * | -1.23 x |
Net cash position 2024 * | 127M 117M 9.96B | Net cash position 2025 * | 54.53M 50.16M 4.26B | EV / Sales 2025 * | 0.42 x |
P/E ratio 2024 * |
-0.73
x | P/E ratio 2025 * |
-1.39
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 week | -1.46% | ||
Current month | +3.05% | ||
1 month | -4.93% | ||
3 months | -84.48% | ||
6 months | -80.29% | ||
Current year | -86.29% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 04/09/18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 11/04/21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 05/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 30/11/08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 04/09/18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 11/12/19 |
Date | Price | Change |
---|---|---|
05/06/24 | 1.32 | -2.22% |
04/06/24 | 1.35 | -3.57% |
03/06/24 | 1.4 | +6.87% |
31/05/24 | 1.31 | -5.07% |
30/05/24 | 1.38 | -0.72% |
Delayed Quote Börse Stuttgart, June 05, 2024 at 12:08 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.69% | 750B | |
+34.11% | 606B | |
-6.87% | 356B | |
+18.74% | 326B | |
+6.76% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.64% | 167B |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock